We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02374450
Recruitment Status : Active, not recruiting
First Posted : February 27, 2015
Last Update Posted : May 19, 2022
Sponsor:
Collaborators:
PATH
AMP (Agence de Médecine Préventive) (in French)
RAFT (Réseau en Afrique Francophone pour la Télémédecine) (in French)
Iqvia Pty Ltd
Parexel (Mobile Phone Alert System Provider)
CLS (Clinical Laboratory Services)
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 2, 2022
Estimated Study Completion Date : August 2, 2022